Systematic identification of genomic markers of drug sensitivity in cancer cells
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 mixed. The earliest on record is from 2018.
Replications
- Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells, Vanden Heuvel et al. (2018). eLife. Outcome recorded: mixed.
mouse mesenchymal cells transformed with either the EWS-FLI1 or FUS-CHOP rearrangement displayed similar sensitivities to olaparib, whereas the Ewing's sarcoma cell line SK-N-MC had increased olaparib sensitivity.
Outcome read from the abstract. View paper
Cite this record
Garnett, M. J., Edelman, E. J., Heidorn, S. J., Greenman, C. D., Dastur, A., Lau, K. W., Greninger, P., Thompson, I. R., Luo, X., Soares, J., Liu, Q., Iorio, F., Surdez, D., Chen, L., Milano, R. J., Bignell, G. R., Tam, A. T., Davies, H., Stevenson, J. A., … Benes, C. H. (2012). Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature, 483(7391), 570–575. https://doi.org/10.1038/nature11005
Other studies in the atlas
Failed replications · Successful replications · All browse pages